Medical Care
Global mRNA Synthesis & Manufacturing Market Outlook, In‑Depth Analysis & Forecast to 2031
- Oct 04, 25
- ID: 535892
- Pages: 142
- Figures: 144
- Views: 3
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global mRNA Synthesis & Manufacturing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Merck KGaA
Thermo Fisher Scientific
GenScript
New England Biolabs
Aldevron
Promega Corporation
Sartorius
WuXi Biologics
Takara Bio
GENEWIZ
TriLink BioTechnologies
Lonza
Telesis Bio
ST Pharm
Aurigene Pharmaceutical Services
Segment by Type
Synthesis
Purification
Manufacturing & Scale-up
Segment by Application
CGT Drugs
Vaccines
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the mRNA Synthesis & Manufacturing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global mRNA Synthesis & Manufacturing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Merck KGaA
Thermo Fisher Scientific
GenScript
New England Biolabs
Aldevron
Promega Corporation
Sartorius
WuXi Biologics
Takara Bio
GENEWIZ
TriLink BioTechnologies
Lonza
Telesis Bio
ST Pharm
Aurigene Pharmaceutical Services
Segment by Type
Synthesis
Purification
Manufacturing & Scale-up
Segment by Application
CGT Drugs
Vaccines
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the mRNA Synthesis & Manufacturing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to mRNA Synthesis & Manufacturing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global mRNA Synthesis & Manufacturing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Synthesis
1.2.3 Purification
1.2.4 Manufacturing & Scale-up
1.3 Market Segmentation by Application
1.3.1 Global mRNA Synthesis & Manufacturing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 CGT Drugs
1.3.3 Vaccines
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global mRNA Synthesis & Manufacturing Revenue Estimates and Forecasts 2020-2031
2.2 Global mRNA Synthesis & Manufacturing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global mRNA Synthesis & Manufacturing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global mRNA Synthesis & Manufacturing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Synthesis Market Size by Players
3.3.2 Purification Market Size by Players
3.3.3 Manufacturing & Scale-up Market Size by Players
3.4 Global mRNA Synthesis & Manufacturing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global mRNA Synthesis & Manufacturing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global mRNA Synthesis & Manufacturing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America mRNA Synthesis & Manufacturing Market Size by Type (2020-2031)
6.4 North America mRNA Synthesis & Manufacturing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America mRNA Synthesis & Manufacturing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe mRNA Synthesis & Manufacturing Market Size by Type (2020-2031)
7.4 Europe mRNA Synthesis & Manufacturing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe mRNA Synthesis & Manufacturing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific mRNA Synthesis & Manufacturing Market Size by Type (2020-2031)
8.4 Asia-Pacific mRNA Synthesis & Manufacturing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific mRNA Synthesis & Manufacturing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America mRNA Synthesis & Manufacturing Market Size by Type (2020-2031)
9.4 Central and South America mRNA Synthesis & Manufacturing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America mRNA Synthesis & Manufacturing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa mRNA Synthesis & Manufacturing Market Size by Type (2020-2031)
10.4 Middle East and Africa mRNA Synthesis & Manufacturing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa mRNA Synthesis & Manufacturing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Merck KGaA
11.1.1 Merck KGaA Corporation Information
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA mRNA Synthesis & Manufacturing Product Features and Attributes
11.1.4 Merck KGaA mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.1.5 Merck KGaA mRNA Synthesis & Manufacturing Revenue by Product in 2024
11.1.6 Merck KGaA mRNA Synthesis & Manufacturing Revenue by Application in 2024
11.1.7 Merck KGaA mRNA Synthesis & Manufacturing Revenue by Geographic Area in 2024
11.1.8 Merck KGaA mRNA Synthesis & Manufacturing SWOT Analysis
11.1.9 Merck KGaA Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific mRNA Synthesis & Manufacturing Product Features and Attributes
11.2.4 Thermo Fisher Scientific mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Scientific mRNA Synthesis & Manufacturing Revenue by Product in 2024
11.2.6 Thermo Fisher Scientific mRNA Synthesis & Manufacturing Revenue by Application in 2024
11.2.7 Thermo Fisher Scientific mRNA Synthesis & Manufacturing Revenue by Geographic Area in 2024
11.2.8 Thermo Fisher Scientific mRNA Synthesis & Manufacturing SWOT Analysis
11.2.9 Thermo Fisher Scientific Recent Developments
11.3 GenScript
11.3.1 GenScript Corporation Information
11.3.2 GenScript Business Overview
11.3.3 GenScript mRNA Synthesis & Manufacturing Product Features and Attributes
11.3.4 GenScript mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.3.5 GenScript mRNA Synthesis & Manufacturing Revenue by Product in 2024
11.3.6 GenScript mRNA Synthesis & Manufacturing Revenue by Application in 2024
11.3.7 GenScript mRNA Synthesis & Manufacturing Revenue by Geographic Area in 2024
11.3.8 GenScript mRNA Synthesis & Manufacturing SWOT Analysis
11.3.9 GenScript Recent Developments
11.4 New England Biolabs
11.4.1 New England Biolabs Corporation Information
11.4.2 New England Biolabs Business Overview
11.4.3 New England Biolabs mRNA Synthesis & Manufacturing Product Features and Attributes
11.4.4 New England Biolabs mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.4.5 New England Biolabs mRNA Synthesis & Manufacturing Revenue by Product in 2024
11.4.6 New England Biolabs mRNA Synthesis & Manufacturing Revenue by Application in 2024
11.4.7 New England Biolabs mRNA Synthesis & Manufacturing Revenue by Geographic Area in 2024
11.4.8 New England Biolabs mRNA Synthesis & Manufacturing SWOT Analysis
11.4.9 New England Biolabs Recent Developments
11.5 Aldevron
11.5.1 Aldevron Corporation Information
11.5.2 Aldevron Business Overview
11.5.3 Aldevron mRNA Synthesis & Manufacturing Product Features and Attributes
11.5.4 Aldevron mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.5.5 Aldevron mRNA Synthesis & Manufacturing Revenue by Product in 2024
11.5.6 Aldevron mRNA Synthesis & Manufacturing Revenue by Application in 2024
11.5.7 Aldevron mRNA Synthesis & Manufacturing Revenue by Geographic Area in 2024
11.5.8 Aldevron mRNA Synthesis & Manufacturing SWOT Analysis
11.5.9 Aldevron Recent Developments
11.6 Promega Corporation
11.6.1 Promega Corporation Corporation Information
11.6.2 Promega Corporation Business Overview
11.6.3 Promega Corporation mRNA Synthesis & Manufacturing Product Features and Attributes
11.6.4 Promega Corporation mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.6.5 Promega Corporation Recent Developments
11.7 Sartorius
11.7.1 Sartorius Corporation Information
11.7.2 Sartorius Business Overview
11.7.3 Sartorius mRNA Synthesis & Manufacturing Product Features and Attributes
11.7.4 Sartorius mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.7.5 Sartorius Recent Developments
11.8 WuXi Biologics
11.8.1 WuXi Biologics Corporation Information
11.8.2 WuXi Biologics Business Overview
11.8.3 WuXi Biologics mRNA Synthesis & Manufacturing Product Features and Attributes
11.8.4 WuXi Biologics mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.8.5 WuXi Biologics Recent Developments
11.9 Takara Bio
11.9.1 Takara Bio Corporation Information
11.9.2 Takara Bio Business Overview
11.9.3 Takara Bio mRNA Synthesis & Manufacturing Product Features and Attributes
11.9.4 Takara Bio mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.9.5 Takara Bio Recent Developments
11.10 GENEWIZ
11.10.1 GENEWIZ Corporation Information
11.10.2 GENEWIZ Business Overview
11.10.3 GENEWIZ mRNA Synthesis & Manufacturing Product Features and Attributes
11.10.4 GENEWIZ mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 TriLink BioTechnologies
11.11.1 TriLink BioTechnologies Corporation Information
11.11.2 TriLink BioTechnologies Business Overview
11.11.3 TriLink BioTechnologies mRNA Synthesis & Manufacturing Product Features and Attributes
11.11.4 TriLink BioTechnologies mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.11.5 TriLink BioTechnologies Recent Developments
11.12 Lonza
11.12.1 Lonza Corporation Information
11.12.2 Lonza Business Overview
11.12.3 Lonza mRNA Synthesis & Manufacturing Product Features and Attributes
11.12.4 Lonza mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.12.5 Lonza Recent Developments
11.13 Telesis Bio
11.13.1 Telesis Bio Corporation Information
11.13.2 Telesis Bio Business Overview
11.13.3 Telesis Bio mRNA Synthesis & Manufacturing Product Features and Attributes
11.13.4 Telesis Bio mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.13.5 Telesis Bio Recent Developments
11.14 ST Pharm
11.14.1 ST Pharm Corporation Information
11.14.2 ST Pharm Business Overview
11.14.3 ST Pharm mRNA Synthesis & Manufacturing Product Features and Attributes
11.14.4 ST Pharm mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.14.5 ST Pharm Recent Developments
11.15 Aurigene Pharmaceutical Services
11.15.1 Aurigene Pharmaceutical Services Corporation Information
11.15.2 Aurigene Pharmaceutical Services Business Overview
11.15.3 Aurigene Pharmaceutical Services mRNA Synthesis & Manufacturing Product Features and Attributes
11.15.4 Aurigene Pharmaceutical Services mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.15.5 Aurigene Pharmaceutical Services Recent Developments
12 mRNA Synthesis & ManufacturingIndustry Chain Analysis
12.1 mRNA Synthesis & Manufacturing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 mRNA Synthesis & Manufacturing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global mRNA Synthesis & Manufacturing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to mRNA Synthesis & Manufacturing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global mRNA Synthesis & Manufacturing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Synthesis
1.2.3 Purification
1.2.4 Manufacturing & Scale-up
1.3 Market Segmentation by Application
1.3.1 Global mRNA Synthesis & Manufacturing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 CGT Drugs
1.3.3 Vaccines
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global mRNA Synthesis & Manufacturing Revenue Estimates and Forecasts 2020-2031
2.2 Global mRNA Synthesis & Manufacturing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global mRNA Synthesis & Manufacturing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global mRNA Synthesis & Manufacturing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Synthesis Market Size by Players
3.3.2 Purification Market Size by Players
3.3.3 Manufacturing & Scale-up Market Size by Players
3.4 Global mRNA Synthesis & Manufacturing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global mRNA Synthesis & Manufacturing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global mRNA Synthesis & Manufacturing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America mRNA Synthesis & Manufacturing Market Size by Type (2020-2031)
6.4 North America mRNA Synthesis & Manufacturing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America mRNA Synthesis & Manufacturing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe mRNA Synthesis & Manufacturing Market Size by Type (2020-2031)
7.4 Europe mRNA Synthesis & Manufacturing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe mRNA Synthesis & Manufacturing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific mRNA Synthesis & Manufacturing Market Size by Type (2020-2031)
8.4 Asia-Pacific mRNA Synthesis & Manufacturing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific mRNA Synthesis & Manufacturing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America mRNA Synthesis & Manufacturing Market Size by Type (2020-2031)
9.4 Central and South America mRNA Synthesis & Manufacturing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America mRNA Synthesis & Manufacturing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa mRNA Synthesis & Manufacturing Market Size by Type (2020-2031)
10.4 Middle East and Africa mRNA Synthesis & Manufacturing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa mRNA Synthesis & Manufacturing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Merck KGaA
11.1.1 Merck KGaA Corporation Information
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA mRNA Synthesis & Manufacturing Product Features and Attributes
11.1.4 Merck KGaA mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.1.5 Merck KGaA mRNA Synthesis & Manufacturing Revenue by Product in 2024
11.1.6 Merck KGaA mRNA Synthesis & Manufacturing Revenue by Application in 2024
11.1.7 Merck KGaA mRNA Synthesis & Manufacturing Revenue by Geographic Area in 2024
11.1.8 Merck KGaA mRNA Synthesis & Manufacturing SWOT Analysis
11.1.9 Merck KGaA Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific mRNA Synthesis & Manufacturing Product Features and Attributes
11.2.4 Thermo Fisher Scientific mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Scientific mRNA Synthesis & Manufacturing Revenue by Product in 2024
11.2.6 Thermo Fisher Scientific mRNA Synthesis & Manufacturing Revenue by Application in 2024
11.2.7 Thermo Fisher Scientific mRNA Synthesis & Manufacturing Revenue by Geographic Area in 2024
11.2.8 Thermo Fisher Scientific mRNA Synthesis & Manufacturing SWOT Analysis
11.2.9 Thermo Fisher Scientific Recent Developments
11.3 GenScript
11.3.1 GenScript Corporation Information
11.3.2 GenScript Business Overview
11.3.3 GenScript mRNA Synthesis & Manufacturing Product Features and Attributes
11.3.4 GenScript mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.3.5 GenScript mRNA Synthesis & Manufacturing Revenue by Product in 2024
11.3.6 GenScript mRNA Synthesis & Manufacturing Revenue by Application in 2024
11.3.7 GenScript mRNA Synthesis & Manufacturing Revenue by Geographic Area in 2024
11.3.8 GenScript mRNA Synthesis & Manufacturing SWOT Analysis
11.3.9 GenScript Recent Developments
11.4 New England Biolabs
11.4.1 New England Biolabs Corporation Information
11.4.2 New England Biolabs Business Overview
11.4.3 New England Biolabs mRNA Synthesis & Manufacturing Product Features and Attributes
11.4.4 New England Biolabs mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.4.5 New England Biolabs mRNA Synthesis & Manufacturing Revenue by Product in 2024
11.4.6 New England Biolabs mRNA Synthesis & Manufacturing Revenue by Application in 2024
11.4.7 New England Biolabs mRNA Synthesis & Manufacturing Revenue by Geographic Area in 2024
11.4.8 New England Biolabs mRNA Synthesis & Manufacturing SWOT Analysis
11.4.9 New England Biolabs Recent Developments
11.5 Aldevron
11.5.1 Aldevron Corporation Information
11.5.2 Aldevron Business Overview
11.5.3 Aldevron mRNA Synthesis & Manufacturing Product Features and Attributes
11.5.4 Aldevron mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.5.5 Aldevron mRNA Synthesis & Manufacturing Revenue by Product in 2024
11.5.6 Aldevron mRNA Synthesis & Manufacturing Revenue by Application in 2024
11.5.7 Aldevron mRNA Synthesis & Manufacturing Revenue by Geographic Area in 2024
11.5.8 Aldevron mRNA Synthesis & Manufacturing SWOT Analysis
11.5.9 Aldevron Recent Developments
11.6 Promega Corporation
11.6.1 Promega Corporation Corporation Information
11.6.2 Promega Corporation Business Overview
11.6.3 Promega Corporation mRNA Synthesis & Manufacturing Product Features and Attributes
11.6.4 Promega Corporation mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.6.5 Promega Corporation Recent Developments
11.7 Sartorius
11.7.1 Sartorius Corporation Information
11.7.2 Sartorius Business Overview
11.7.3 Sartorius mRNA Synthesis & Manufacturing Product Features and Attributes
11.7.4 Sartorius mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.7.5 Sartorius Recent Developments
11.8 WuXi Biologics
11.8.1 WuXi Biologics Corporation Information
11.8.2 WuXi Biologics Business Overview
11.8.3 WuXi Biologics mRNA Synthesis & Manufacturing Product Features and Attributes
11.8.4 WuXi Biologics mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.8.5 WuXi Biologics Recent Developments
11.9 Takara Bio
11.9.1 Takara Bio Corporation Information
11.9.2 Takara Bio Business Overview
11.9.3 Takara Bio mRNA Synthesis & Manufacturing Product Features and Attributes
11.9.4 Takara Bio mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.9.5 Takara Bio Recent Developments
11.10 GENEWIZ
11.10.1 GENEWIZ Corporation Information
11.10.2 GENEWIZ Business Overview
11.10.3 GENEWIZ mRNA Synthesis & Manufacturing Product Features and Attributes
11.10.4 GENEWIZ mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 TriLink BioTechnologies
11.11.1 TriLink BioTechnologies Corporation Information
11.11.2 TriLink BioTechnologies Business Overview
11.11.3 TriLink BioTechnologies mRNA Synthesis & Manufacturing Product Features and Attributes
11.11.4 TriLink BioTechnologies mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.11.5 TriLink BioTechnologies Recent Developments
11.12 Lonza
11.12.1 Lonza Corporation Information
11.12.2 Lonza Business Overview
11.12.3 Lonza mRNA Synthesis & Manufacturing Product Features and Attributes
11.12.4 Lonza mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.12.5 Lonza Recent Developments
11.13 Telesis Bio
11.13.1 Telesis Bio Corporation Information
11.13.2 Telesis Bio Business Overview
11.13.3 Telesis Bio mRNA Synthesis & Manufacturing Product Features and Attributes
11.13.4 Telesis Bio mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.13.5 Telesis Bio Recent Developments
11.14 ST Pharm
11.14.1 ST Pharm Corporation Information
11.14.2 ST Pharm Business Overview
11.14.3 ST Pharm mRNA Synthesis & Manufacturing Product Features and Attributes
11.14.4 ST Pharm mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.14.5 ST Pharm Recent Developments
11.15 Aurigene Pharmaceutical Services
11.15.1 Aurigene Pharmaceutical Services Corporation Information
11.15.2 Aurigene Pharmaceutical Services Business Overview
11.15.3 Aurigene Pharmaceutical Services mRNA Synthesis & Manufacturing Product Features and Attributes
11.15.4 Aurigene Pharmaceutical Services mRNA Synthesis & Manufacturing Revenue and Gross Margin (2020-2025)
11.15.5 Aurigene Pharmaceutical Services Recent Developments
12 mRNA Synthesis & ManufacturingIndustry Chain Analysis
12.1 mRNA Synthesis & Manufacturing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 mRNA Synthesis & Manufacturing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global mRNA Synthesis & Manufacturing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global mRNA Synthesis & Manufacturing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global mRNA Synthesis & Manufacturing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global mRNA Synthesis & Manufacturing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global mRNA Synthesis & Manufacturing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global mRNA Synthesis & Manufacturing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global mRNA Synthesis & Manufacturing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global mRNA Synthesis & Manufacturing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global mRNA Synthesis & Manufacturing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Synthesis & Manufacturing as of 2024)
Table 11. Global mRNA Synthesis & Manufacturing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global mRNA Synthesis & Manufacturing Companies Headquarters
Table 13. Global mRNA Synthesis & Manufacturing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global mRNA Synthesis & Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global mRNA Synthesis & Manufacturing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global mRNA Synthesis & Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global mRNA Synthesis & Manufacturing Revenue by Application (2026-2031) & (US$ Million)
Table 21. mRNA Synthesis & Manufacturing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America mRNA Synthesis & Manufacturing Growth Accelerators and Market Barriers
Table 25. North America mRNA Synthesis & Manufacturing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe mRNA Synthesis & Manufacturing Growth Accelerators and Market Barriers
Table 27. Europe mRNA Synthesis & Manufacturing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific mRNA Synthesis & Manufacturing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific mRNA Synthesis & Manufacturing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America mRNA Synthesis & Manufacturing Investment Opportunities and Key Challenges
Table 31. Central and South America mRNA Synthesis & Manufacturing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa mRNA Synthesis & Manufacturing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa mRNA Synthesis & Manufacturing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Merck KGaA Corporation Information
Table 35. Merck KGaA Description and Major Businesses
Table 36. Merck KGaA Product Features and Attributes
Table 37. Merck KGaA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Merck KGaA Revenue Proportion by Product in 2024
Table 39. Merck KGaA Revenue Proportion by Application in 2024
Table 40. Merck KGaA Revenue Proportion by Geographic Area in 2024
Table 41. Merck KGaA mRNA Synthesis & Manufacturing SWOT Analysis
Table 42. Merck KGaA Recent Developments
Table 43. Thermo Fisher Scientific Corporation Information
Table 44. Thermo Fisher Scientific Description and Major Businesses
Table 45. Thermo Fisher Scientific Product Features and Attributes
Table 46. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 48. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 49. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 50. Thermo Fisher Scientific mRNA Synthesis & Manufacturing SWOT Analysis
Table 51. Thermo Fisher Scientific Recent Developments
Table 52. GenScript Corporation Information
Table 53. GenScript Description and Major Businesses
Table 54. GenScript Product Features and Attributes
Table 55. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. GenScript Revenue Proportion by Product in 2024
Table 57. GenScript Revenue Proportion by Application in 2024
Table 58. GenScript Revenue Proportion by Geographic Area in 2024
Table 59. GenScript mRNA Synthesis & Manufacturing SWOT Analysis
Table 60. GenScript Recent Developments
Table 61. New England Biolabs Corporation Information
Table 62. New England Biolabs Description and Major Businesses
Table 63. New England Biolabs Product Features and Attributes
Table 64. New England Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. New England Biolabs Revenue Proportion by Product in 2024
Table 66. New England Biolabs Revenue Proportion by Application in 2024
Table 67. New England Biolabs Revenue Proportion by Geographic Area in 2024
Table 68. New England Biolabs mRNA Synthesis & Manufacturing SWOT Analysis
Table 69. New England Biolabs Recent Developments
Table 70. Aldevron Corporation Information
Table 71. Aldevron Description and Major Businesses
Table 72. Aldevron Product Features and Attributes
Table 73. Aldevron Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Aldevron Revenue Proportion by Product in 2024
Table 75. Aldevron Revenue Proportion by Application in 2024
Table 76. Aldevron Revenue Proportion by Geographic Area in 2024
Table 77. Aldevron mRNA Synthesis & Manufacturing SWOT Analysis
Table 78. Aldevron Recent Developments
Table 79. Promega Corporation Corporation Information
Table 80. Promega Corporation Description and Major Businesses
Table 81. Promega Corporation Product Features and Attributes
Table 82. Promega Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Promega Corporation Recent Developments
Table 84. Sartorius Corporation Information
Table 85. Sartorius Description and Major Businesses
Table 86. Sartorius Product Features and Attributes
Table 87. Sartorius Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Sartorius Recent Developments
Table 89. WuXi Biologics Corporation Information
Table 90. WuXi Biologics Description and Major Businesses
Table 91. WuXi Biologics Product Features and Attributes
Table 92. WuXi Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. WuXi Biologics Recent Developments
Table 94. Takara Bio Corporation Information
Table 95. Takara Bio Description and Major Businesses
Table 96. Takara Bio Product Features and Attributes
Table 97. Takara Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Takara Bio Recent Developments
Table 99. GENEWIZ Corporation Information
Table 100. GENEWIZ Description and Major Businesses
Table 101. GENEWIZ Product Features and Attributes
Table 102. GENEWIZ Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. GENEWIZ Recent Developments
Table 104. TriLink BioTechnologies Corporation Information
Table 105. TriLink BioTechnologies Description and Major Businesses
Table 106. TriLink BioTechnologies Product Features and Attributes
Table 107. TriLink BioTechnologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. TriLink BioTechnologies Recent Developments
Table 109. Lonza Corporation Information
Table 110. Lonza Description and Major Businesses
Table 111. Lonza Product Features and Attributes
Table 112. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Lonza Recent Developments
Table 114. Telesis Bio Corporation Information
Table 115. Telesis Bio Description and Major Businesses
Table 116. Telesis Bio Product Features and Attributes
Table 117. Telesis Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Telesis Bio Recent Developments
Table 119. ST Pharm Corporation Information
Table 120. ST Pharm Description and Major Businesses
Table 121. ST Pharm Product Features and Attributes
Table 122. ST Pharm Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. ST Pharm Recent Developments
Table 124. Aurigene Pharmaceutical Services Corporation Information
Table 125. Aurigene Pharmaceutical Services Description and Major Businesses
Table 126. Aurigene Pharmaceutical Services Product Features and Attributes
Table 127. Aurigene Pharmaceutical Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Aurigene Pharmaceutical Services Recent Developments
Table 129. Raw Materials Key Suppliers
Table 130. Distributors List
Table 131. Market Trends and Market Evolution
Table 132. Market Drivers and Opportunities
Table 133. Market Challenges, Risks, and Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Synthesis & Manufacturing Product Picture
Figure 2. Global mRNA Synthesis & Manufacturing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Synthesis Product Picture
Figure 4. Purification Product Picture
Figure 5. Manufacturing & Scale-up Product Picture
Figure 6. Global mRNA Synthesis & Manufacturing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. CGT Drugs
Figure 8. Vaccines
Figure 9. mRNA Synthesis & Manufacturing Report Years Considered
Figure 10. Global mRNA Synthesis & Manufacturing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 12. Global mRNA Synthesis & Manufacturing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global mRNA Synthesis & Manufacturing Revenue Market Share by Region (2020-2031)
Figure 14. Global mRNA Synthesis & Manufacturing Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Synthesis Revenue Market Share by Player in 2024
Figure 17. Purification Revenue Market Share by Player in 2024
Figure 18. Manufacturing & Scale-up Revenue Market Share by Player in 2024
Figure 19. Global mRNA Synthesis & Manufacturing Revenue Market Share by Type (2020-2031)
Figure 20. Global mRNA Synthesis & Manufacturing Revenue Market Share by Application (2020-2031)
Figure 21. North America mRNA Synthesis & Manufacturing Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players mRNA Synthesis & Manufacturing Revenue (US$ Million) in 2024
Figure 23. North America mRNA Synthesis & Manufacturing Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America mRNA Synthesis & Manufacturing Revenue (US$ Million) by Application (2020-2031)
Figure 25. US mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 26. Canada mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 28. Europe mRNA Synthesis & Manufacturing Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players mRNA Synthesis & Manufacturing Revenue (US$ Million) in 2024
Figure 30. Europe mRNA Synthesis & Manufacturing Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe mRNA Synthesis & Manufacturing Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 33. France mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 35. Italy mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 36. Russia mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific mRNA Synthesis & Manufacturing Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players mRNA Synthesis & Manufacturing Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific mRNA Synthesis & Manufacturing Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific mRNA Synthesis & Manufacturing Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 42. Japan mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 44. Australia mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 45. India mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America mRNA Synthesis & Manufacturing Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players mRNA Synthesis & Manufacturing Revenue (US$ Million) in 2024
Figure 53. Central and South America mRNA Synthesis & Manufacturing Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America mRNA Synthesis & Manufacturing Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil mRNA Synthesis & Manufacturing Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina mRNA Synthesis & Manufacturing Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa mRNA Synthesis & Manufacturing Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players mRNA Synthesis & Manufacturing Revenue (US$ Million) in 2024
Figure 59. South America mRNA Synthesis & Manufacturing Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa mRNA Synthesis & Manufacturing Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries mRNA Synthesis & Manufacturing Revenue (2020-2025) & (US$ Million)
Figure 62. Israel mRNA Synthesis & Manufacturing Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt mRNA Synthesis & Manufacturing Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa mRNA Synthesis & Manufacturing Revenue (2020-2025) & (US$ Million)
Figure 65. mRNA Synthesis & Manufacturing Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global mRNA Synthesis & Manufacturing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global mRNA Synthesis & Manufacturing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global mRNA Synthesis & Manufacturing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global mRNA Synthesis & Manufacturing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global mRNA Synthesis & Manufacturing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global mRNA Synthesis & Manufacturing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global mRNA Synthesis & Manufacturing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global mRNA Synthesis & Manufacturing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Synthesis & Manufacturing as of 2024)
Table 11. Global mRNA Synthesis & Manufacturing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global mRNA Synthesis & Manufacturing Companies Headquarters
Table 13. Global mRNA Synthesis & Manufacturing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global mRNA Synthesis & Manufacturing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global mRNA Synthesis & Manufacturing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global mRNA Synthesis & Manufacturing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global mRNA Synthesis & Manufacturing Revenue by Application (2026-2031) & (US$ Million)
Table 21. mRNA Synthesis & Manufacturing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America mRNA Synthesis & Manufacturing Growth Accelerators and Market Barriers
Table 25. North America mRNA Synthesis & Manufacturing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe mRNA Synthesis & Manufacturing Growth Accelerators and Market Barriers
Table 27. Europe mRNA Synthesis & Manufacturing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific mRNA Synthesis & Manufacturing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific mRNA Synthesis & Manufacturing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America mRNA Synthesis & Manufacturing Investment Opportunities and Key Challenges
Table 31. Central and South America mRNA Synthesis & Manufacturing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa mRNA Synthesis & Manufacturing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa mRNA Synthesis & Manufacturing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Merck KGaA Corporation Information
Table 35. Merck KGaA Description and Major Businesses
Table 36. Merck KGaA Product Features and Attributes
Table 37. Merck KGaA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Merck KGaA Revenue Proportion by Product in 2024
Table 39. Merck KGaA Revenue Proportion by Application in 2024
Table 40. Merck KGaA Revenue Proportion by Geographic Area in 2024
Table 41. Merck KGaA mRNA Synthesis & Manufacturing SWOT Analysis
Table 42. Merck KGaA Recent Developments
Table 43. Thermo Fisher Scientific Corporation Information
Table 44. Thermo Fisher Scientific Description and Major Businesses
Table 45. Thermo Fisher Scientific Product Features and Attributes
Table 46. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 48. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 49. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 50. Thermo Fisher Scientific mRNA Synthesis & Manufacturing SWOT Analysis
Table 51. Thermo Fisher Scientific Recent Developments
Table 52. GenScript Corporation Information
Table 53. GenScript Description and Major Businesses
Table 54. GenScript Product Features and Attributes
Table 55. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. GenScript Revenue Proportion by Product in 2024
Table 57. GenScript Revenue Proportion by Application in 2024
Table 58. GenScript Revenue Proportion by Geographic Area in 2024
Table 59. GenScript mRNA Synthesis & Manufacturing SWOT Analysis
Table 60. GenScript Recent Developments
Table 61. New England Biolabs Corporation Information
Table 62. New England Biolabs Description and Major Businesses
Table 63. New England Biolabs Product Features and Attributes
Table 64. New England Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. New England Biolabs Revenue Proportion by Product in 2024
Table 66. New England Biolabs Revenue Proportion by Application in 2024
Table 67. New England Biolabs Revenue Proportion by Geographic Area in 2024
Table 68. New England Biolabs mRNA Synthesis & Manufacturing SWOT Analysis
Table 69. New England Biolabs Recent Developments
Table 70. Aldevron Corporation Information
Table 71. Aldevron Description and Major Businesses
Table 72. Aldevron Product Features and Attributes
Table 73. Aldevron Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Aldevron Revenue Proportion by Product in 2024
Table 75. Aldevron Revenue Proportion by Application in 2024
Table 76. Aldevron Revenue Proportion by Geographic Area in 2024
Table 77. Aldevron mRNA Synthesis & Manufacturing SWOT Analysis
Table 78. Aldevron Recent Developments
Table 79. Promega Corporation Corporation Information
Table 80. Promega Corporation Description and Major Businesses
Table 81. Promega Corporation Product Features and Attributes
Table 82. Promega Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Promega Corporation Recent Developments
Table 84. Sartorius Corporation Information
Table 85. Sartorius Description and Major Businesses
Table 86. Sartorius Product Features and Attributes
Table 87. Sartorius Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Sartorius Recent Developments
Table 89. WuXi Biologics Corporation Information
Table 90. WuXi Biologics Description and Major Businesses
Table 91. WuXi Biologics Product Features and Attributes
Table 92. WuXi Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. WuXi Biologics Recent Developments
Table 94. Takara Bio Corporation Information
Table 95. Takara Bio Description and Major Businesses
Table 96. Takara Bio Product Features and Attributes
Table 97. Takara Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Takara Bio Recent Developments
Table 99. GENEWIZ Corporation Information
Table 100. GENEWIZ Description and Major Businesses
Table 101. GENEWIZ Product Features and Attributes
Table 102. GENEWIZ Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. GENEWIZ Recent Developments
Table 104. TriLink BioTechnologies Corporation Information
Table 105. TriLink BioTechnologies Description and Major Businesses
Table 106. TriLink BioTechnologies Product Features and Attributes
Table 107. TriLink BioTechnologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. TriLink BioTechnologies Recent Developments
Table 109. Lonza Corporation Information
Table 110. Lonza Description and Major Businesses
Table 111. Lonza Product Features and Attributes
Table 112. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Lonza Recent Developments
Table 114. Telesis Bio Corporation Information
Table 115. Telesis Bio Description and Major Businesses
Table 116. Telesis Bio Product Features and Attributes
Table 117. Telesis Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Telesis Bio Recent Developments
Table 119. ST Pharm Corporation Information
Table 120. ST Pharm Description and Major Businesses
Table 121. ST Pharm Product Features and Attributes
Table 122. ST Pharm Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. ST Pharm Recent Developments
Table 124. Aurigene Pharmaceutical Services Corporation Information
Table 125. Aurigene Pharmaceutical Services Description and Major Businesses
Table 126. Aurigene Pharmaceutical Services Product Features and Attributes
Table 127. Aurigene Pharmaceutical Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Aurigene Pharmaceutical Services Recent Developments
Table 129. Raw Materials Key Suppliers
Table 130. Distributors List
Table 131. Market Trends and Market Evolution
Table 132. Market Drivers and Opportunities
Table 133. Market Challenges, Risks, and Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Synthesis & Manufacturing Product Picture
Figure 2. Global mRNA Synthesis & Manufacturing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Synthesis Product Picture
Figure 4. Purification Product Picture
Figure 5. Manufacturing & Scale-up Product Picture
Figure 6. Global mRNA Synthesis & Manufacturing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. CGT Drugs
Figure 8. Vaccines
Figure 9. mRNA Synthesis & Manufacturing Report Years Considered
Figure 10. Global mRNA Synthesis & Manufacturing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 12. Global mRNA Synthesis & Manufacturing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global mRNA Synthesis & Manufacturing Revenue Market Share by Region (2020-2031)
Figure 14. Global mRNA Synthesis & Manufacturing Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Synthesis Revenue Market Share by Player in 2024
Figure 17. Purification Revenue Market Share by Player in 2024
Figure 18. Manufacturing & Scale-up Revenue Market Share by Player in 2024
Figure 19. Global mRNA Synthesis & Manufacturing Revenue Market Share by Type (2020-2031)
Figure 20. Global mRNA Synthesis & Manufacturing Revenue Market Share by Application (2020-2031)
Figure 21. North America mRNA Synthesis & Manufacturing Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players mRNA Synthesis & Manufacturing Revenue (US$ Million) in 2024
Figure 23. North America mRNA Synthesis & Manufacturing Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America mRNA Synthesis & Manufacturing Revenue (US$ Million) by Application (2020-2031)
Figure 25. US mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 26. Canada mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 28. Europe mRNA Synthesis & Manufacturing Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players mRNA Synthesis & Manufacturing Revenue (US$ Million) in 2024
Figure 30. Europe mRNA Synthesis & Manufacturing Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe mRNA Synthesis & Manufacturing Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 33. France mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 35. Italy mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 36. Russia mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific mRNA Synthesis & Manufacturing Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players mRNA Synthesis & Manufacturing Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific mRNA Synthesis & Manufacturing Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific mRNA Synthesis & Manufacturing Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 42. Japan mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 44. Australia mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 45. India mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore mRNA Synthesis & Manufacturing Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America mRNA Synthesis & Manufacturing Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players mRNA Synthesis & Manufacturing Revenue (US$ Million) in 2024
Figure 53. Central and South America mRNA Synthesis & Manufacturing Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America mRNA Synthesis & Manufacturing Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil mRNA Synthesis & Manufacturing Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina mRNA Synthesis & Manufacturing Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa mRNA Synthesis & Manufacturing Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players mRNA Synthesis & Manufacturing Revenue (US$ Million) in 2024
Figure 59. South America mRNA Synthesis & Manufacturing Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa mRNA Synthesis & Manufacturing Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries mRNA Synthesis & Manufacturing Revenue (2020-2025) & (US$ Million)
Figure 62. Israel mRNA Synthesis & Manufacturing Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt mRNA Synthesis & Manufacturing Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa mRNA Synthesis & Manufacturing Revenue (2020-2025) & (US$ Million)
Figure 65. mRNA Synthesis & Manufacturing Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Spatial Metabolomics Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global Pharmaceutical Process Analytical Technology (PAT) Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Global HASE Rheology Modifiers Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232